Eagle Pharmaceuticals, Inc.
EGRX
$1.90
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.35M | 21.90M | 55.32M | 15.38M | 36.56M |
| Total Receivables | 115.14M | 114.95M | 72.44M | 97.93M | 93.08M |
| Inventory | 42.48M | 44.14M | 47.79M | 63.86M | 57.71M |
| Prepaid Expenses | 2.15M | 3.17M | 3.28M | 537.00K | 1.94M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 12.13M | 8.33M | 9.92M | 7.34M | 5.16M |
| Total Current Assets | 187.25M | 192.49M | 188.75M | 185.05M | 194.46M |
|
|
|||||
| Total Current Assets | 187.25M | 192.49M | 188.75M | 185.05M | 194.46M |
| Net Property, Plant & Equipment | 1.01M | 1.12M | 1.17M | 1.30M | 1.46M |
| Long-term Investments | 45.03M | 45.03M | 45.03M | 41.79M | 43.06M |
| Goodwill | 45.03M | 45.03M | 45.03M | 41.79M | 43.06M |
| Total Other Intangibles | 115.53M | 121.00M | 126.45M | 116.91M | 112.47M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 37.66M | 36.41M | 34.74M | 30.08M | 27.51M |
| Total Assets | 404.82M | 414.18M | 406.16M | 386.45M | 381.76M |
|
|
|||||
| Total Accounts Payable | 15.84M | 17.11M | 18.99M | 13.22M | 19.97M |
| Total Accrued Expenses | 57.45M | 54.81M | 67.59M | 47.90M | 48.06M |
| Short-term Debt | 8.30M | 7.50M | 6.25M | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.42M | 1.59M | 1.53M | 36.47M | 23.32M |
| Total Finance Division Other Current Liabilities | 3.61M | 16.81M | 16.72M | 24.24M | 17.61M |
| Total Other Current Liabilities | 3.61M | 16.81M | 16.72M | 24.24M | 17.61M |
| Total Current Liabilities | 86.63M | 97.81M | 111.09M | 121.83M | 108.96M |
|
|
|||||
| Total Current Liabilities | 86.63M | 97.81M | 111.09M | 121.83M | 108.96M |
| Long-Term Debt | 61.90M | 68.83M | 56.22M | 26.43M | 28.02M |
| Short-term Debt | 8.30M | 7.50M | 6.25M | -- | -- |
| Capital Leases | 839.00K | 1.06M | 1.51M | 1.87M | 2.26M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.42M | 3.64M | 3.79M | 4.54M | 4.54M |
| Total Liabilities | 152.78M | 171.33M | 172.60M | 154.67M | 143.77M |
|
|
|||||
| Common Stock & APIC | 373.85M | 369.82M | 366.28M | 362.18M | 358.40M |
| Retained Earnings | 122.42M | 117.25M | 111.50M | 103.34M | 110.47M |
| Treasury Stock & Other | -244.23M | -244.23M | -244.23M | -233.74M | -230.88M |
| Total Common Equity | 252.04M | 242.85M | 233.56M | 231.78M | 237.98M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 252.04M | 242.85M | 233.56M | 231.78M | 237.98M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 252.04M | 242.85M | 233.56M | 231.78M | 237.98M |
|
|
|||||